The point is a great deal of drug development time did not go away when DNA sequencing and bioinformatics became available, and a great deal will not go away with Alphafold.
> We're headed towards a word where data gets put in a blender to decide what to try next. That entire pipeline can and will be automated.
No, we're not, and no, it will not. Alphabet has an entire large organization trying to bring the benefits of Big Data to traditional sciences. It's not a waste of time by any means. It's also not a steamroller ready to crush every problem in its path.